Crossref journal-article
Springer Science and Business Media LLC
Nature Medicine (297)
Bibliography

Nagata, S. (2000). Steering anti-cancer drugs away from the TRAIL. Nature Medicine, 6(5), 502–503.

Authors 1
  1. Shigekazu Nagata (first)
References 13 Referenced 42
  1. Old, L.J. Tumor necrosis factor (TNF). Science 230, 630–632 (1985). (10.1126/science.2413547) / Science by LJ Old (1985)
  2. Vassalli, P. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10, 411–452 ( 1992). (10.1146/annurev.iy.10.040192.002211) / Annu. Rev. Immunol. by P Vassalli (1992)
  3. Trauth, B.C. et al. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245, 301– 305 (1989). (10.1126/science.2787530) / Science by BC Trauth (1989)
  4. Ogasawara, J. et al. Lethal effect of the anti-Fas antibody in mice. Nature 364, 806–809 ( 1993). (10.1038/364806a0) / Nature by J Ogasawara (1993)
  5. Willey, S.R. et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3, 673–682 (1995). (10.1016/1074-7613(95)90057-8) / Immunity by SR Willey (1995)
  6. Pitti, R.M. et al. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J. Biol. Chem. 271, 12687–12690 (1996). (10.1074/jbc.271.22.12687) / J. Biol. Chem. by RM Pitti (1996)
  7. Walczak, H. et al. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nature Med. 5, 157 –163 (1999). (10.1038/5517) / Nature Med. by H Walczak (1999)
  8. Ashkenazi, A. et al. Safety and antitumor activity of recombinant soluble Apo2 ligand. J. Clin. Invest. 104, 155– 162 (1999). (10.1172/JCI6926) / J. Clin. Invest. by A Ashkenazi (1999)
  9. Jo, M. et al. TNF-related apoptosis inducing ligand (TRAIL)-induced apoptosis in normal human hepatocytes. Nature Med. 6, 564–567 (2000) (10.1038/75045) / Nature Med. by M Jo (2000)
  10. Nagata, S. Apoptosis by death factor. Cell 88, 355– 365 (1997). (10.1016/S0092-8674(00)81874-7) / Cell by S Nagata (1997)
  11. Ashkenazi, A. & Dixit, V.M. Death receptors: signaling and modulation . Science 281, 1305–1308 (1998). (10.1126/science.281.5381.1305) / Science by A Ashkenazi (1998)
  12. Nagata, S. Fas ligand-induced apoptosis. Annu. Rev. Genetics 33 , 29–55 (1999). (10.1146/annurev.genet.33.1.29) / Annu. Rev. Genetics by S Nagata (1999)
  13. Bodmer, J.-L. et al. TRAIL receptor-2 signals apoptosis through FADD and caspase-8 . Nature Cell Biol. 2, 241– 243 (2000). (10.1038/35008667) / Nature Cell Biol. by J-L Bodmer (2000)
Dates
Type When
Created 23 years, 1 month ago (July 26, 2002, 4:34 a.m.)
Deposited 2 years, 3 months ago (May 18, 2023, 6:23 p.m.)
Indexed 3 months, 1 week ago (May 18, 2025, 12:03 p.m.)
Issued 25 years, 3 months ago (May 1, 2000)
Published 25 years, 3 months ago (May 1, 2000)
Published Print 25 years, 3 months ago (May 1, 2000)
Funders 0

None

@article{Nagata_2000, title={Steering anti-cancer drugs away from the TRAIL}, volume={6}, ISSN={1546-170X}, url={http://dx.doi.org/10.1038/74972}, DOI={10.1038/74972}, number={5}, journal={Nature Medicine}, publisher={Springer Science and Business Media LLC}, author={Nagata, Shigekazu}, year={2000}, month=may, pages={502–503} }